KESTRA MEDICAL TECHNOLOGIES, LTD. — Form 10-K

Kestra Medical Technologies, Inc. entered into a loan agreement dated July 10, 2026, with BioPharma Credit PLC as collateral agent and BPCR Limited Partnership and BioPharma Credit Investments V (Master) LP as lenders. The agreement provides for up to four tranches of term loans (Tranche A mandatory, Tranches B-D optional) with interest at Term SOFR plus applicable margin, quarterly amortization (or deferred to maturity upon achievement of revenue trigger), and maturity on an unspecified date. Specific loan amounts, interest rates, maturity date, and financial covenants are redacted from the filing. The facility requires collateral security over substantially all assets, is subject to extensive representations regarding regulatory compliance, intellectual property, cybersecurity, and health care matters.